<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Genome Var</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum Genome Var</journal-id>
<journal-title-group>
<journal-title>Human Genome Variation</journal-title>
</journal-title-group>
<issn pub-type="epub">2054-345X</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30083362</article-id>
<article-id pub-id-type="pmc">6053359</article-id>
<article-id pub-id-type="publisher-id">20</article-id>
<article-id pub-id-type="doi">10.1038/s41439-018-0020-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Data Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Independent occurrence of de novo <italic>HSPD1</italic> and <italic>HIP1</italic> variants in brothers with different neurological disorders – leukodystrophy and autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9484-3505</contrib-id>
<name>
<surname>Yamamoto</surname>
<given-names>Toshiyuki</given-names>
</name>
<address>
<phone>+81-3-3353-8111</phone>
<email>yamamoto.toshiyuki@twmu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamamoto-Shimojima</surname>
<given-names>Keiko</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ueda</surname>
<given-names>Yuki</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imai</surname>
<given-names>Katsumi</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Yukitoshi</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imagawa</surname>
<given-names>Eri</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyake</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsumoto</surname>
<given-names>Naomichi</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0720 6587</institution-id><institution-id institution-id-type="GRID">grid.410818.4</institution-id><institution>Institute of Medical Genetics, </institution><institution>Tokyo Women’s Medical University, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0720 6587</institution-id><institution-id institution-id-type="GRID">grid.410818.4</institution-id><institution>Tokyo Women’s Medical University Institute for Integrated Medical Sciences, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0618 9684</institution-id><institution-id institution-id-type="GRID">grid.419174.e</institution-id><institution>Epilepsy Centre, </institution><institution>NHO Shizuoka Institute of Epilepsy and Neurological Disorders, </institution></institution-wrap>Shizuoka, Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1033 6139</institution-id><institution-id institution-id-type="GRID">grid.268441.d</institution-id><institution>Department of Genetics, </institution><institution>Yokohama City University, </institution></institution-wrap>Yokohama, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>19</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>5</volume>
<elocation-id>18</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Consecutive occurrence of de novo variants in the same family is an extremely rare phenomenon. Two siblings, a younger brother with hypomyelinating leukodystrophy and an elder brother with severe intellectual disability and autistic features, had independent de novo variants of <italic>HSPD1</italic> c.139T &gt; G (p.Leu47Val) and <italic>HIP1</italic> c.1393G &gt; A (p.Glu465Lys), respectively. These novel variants were predicted to be pathogenic. Both patients also had a known <italic>MECP2</italic> variant, c.499C &gt; T (p.Arg167Trp).</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p id="Par2">Hypomyelinating leukodystrophies (HLDs) are caused by congenital dysfunctions of the oligodendroglia and/or astrocytes<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Patients with HLDs show motor developmental delay and other neurological symptoms, including intellectual disability (ID), nystagmus, tremor, and epilepsy. Brain magnetic resonance imaging (MRI) demonstrates –T2-high intensity in the white matter<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. OMIM (<ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link>) registers 13 subgroups of HLDs (Supplemental_Table_<xref ref-type="media" rid="MOESM1">S1</xref>)<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Pelizaeus-Merzbacher disease (PMD; MIM#31208) is the most common HLD in male patients and is classified as HLD1. Because the proteolipid protein 1 gene (<italic>PLP1</italic>) responsible for PMD is located on the X-chromosome, PMD is an X-linked recessive disease.</p>
<p id="Par3">Among HLDs, only HLD6 (MIM#612438) is related to autosomal dominant traits. Most patients with HLD6 have de novo variants in the tubulin beta-4A gene (<italic>TUBB4A</italic>)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, whereas <italic>TUBB4A</italic> is also related to autosomal dominant torsion dystonia 4 (DYT4; MIM#128101). In families with DYT4, <italic>TUBB4A</italic> variants are inherited as autosomal dominant traits. Thus, HLD6 and DYT4 are recognized as allelic disorders. The clinical difference between HLD6 and DYT4 is unclear, and there is an intermediate pattern<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Similarly, the 60-kDa heat shock protein 1 gene (<italic>HSPD1</italic>), responsible for HLD4 (MIM#612233)<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, is associated with spastic paraplegia 13 (SPG13; MIM#605280)<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, suggesting that HLD4 and SPG13 are also allelic disorders.</p>
<p id="Par4">Here, we report on a de novo heterozygous <italic>HSPD1</italic> variant in a sporadic patient with HLD4 but not SPG13 (patient 1, Supplemental <xref ref-type="media" rid="MOESM1">Information</xref>) in association with a de novo variant in the huntingtin-interacting protein 1 gene (<italic>HIP1</italic>), which was concurrently identified in his elder brother (patient 2, Supplemental <xref ref-type="media" rid="MOESM1">Information</xref>).</p>
<p id="Par5">In accordance with the declaration of Helsinki, this study was approved by the ethics committee of Tokyo Women’s Medical University. After receiving written informed consent from the family, we obtained blood samples from siblings and their parents. Genomic DNA was extracted for sequence analysis and used for genetic diagnosis.</p>
<p id="Par6">Because PMD derived from duplications or single-nucleotide alterations in the <italic>PLP1</italic> region is the major type of HLD, <italic>PLP1</italic> analysis by microarray-based comparative genomic hybridization and Sanger sequencing was performed as the first tier<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, and these confirmed no abnormalities. Whole-exome sequencing (WES) was performed for both parents and siblings (patients 1 and 2) as described<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Synonymous variants, variants with more than 1% global population frequency, and variants registered in the Human Genetic Variation Database<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> were filtered. Variants with de novo origin or those showing Mendelian inheritance patterns, associated with autosomal dominant or recessive traits, were manually selected. Pathogenic genomic copy-number variations (CNVs) were not identified by the eXome Hidden Markov Model using the data extracted through WES<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
<p id="Par7">Novel variants, NM_002156.4(HSPD1):c.139T &gt; G (p.Leu47Val) and NM_005338.6(HIP1):c.1393G &gt; A (p.Glu465Lys), were identified in patients 1 and 2, respectively. These variants were not registered in the 1KGP, ExAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>), ESP6500 (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>), or iJGVD database (Supplemental Table <xref ref-type="media" rid="MOESM1">S3</xref>, <xref ref-type="media" rid="MOESM1">4</xref>)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. At the same position on <italic>HIP1</italic> c.1393G &gt; A, there is a known SNP, rs782598703G &gt; C (p.Glu465Gln) (location chr7:75187292), with a minor allele frequency of 0.001% (1/121394). Both patients and their mother carried NM_004992.3(MECP2):c.499C &gt; T (p.Arg167Trp), registered as rs61748420 (Supplemental Table <xref ref-type="media" rid="MOESM1">S2</xref>, <xref ref-type="media" rid="MOESM1">5</xref>), indicating X-linked recessive inheritance. There was no other possible candidate variant in the genes related to the clinical features in association with Mendelian inheritance, including autosomal-recessive traits. The results are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>, together with clinical features. All variants were confirmed by Sanger sequencing (Fig._<xref ref-type="fig" rid="Fig1">1c</xref>), and damaging scores predicted through wANNOVAR (<ext-link ext-link-type="uri" xlink:href="http://wannovar.wglab.org/">http://wannovar.wglab.org/</ext-link>) are listed in Supplemental_Table_<xref ref-type="media" rid="MOESM1">S2</xref>. Most of the scores, including CADD, suggested pathogenicity. The results of wANNOVAR analysis for all previously reported <italic>HSPD1</italic> variants are compared in Supplemental_Table_<xref ref-type="media" rid="MOESM1">S3</xref>, suggesting no significant difference from the present variant. The amino acid sequences affected by all variants discussed in this study are conserved among species (Supplemental_Figure_<xref ref-type="media" rid="MOESM1">S1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of the clinical features and gene variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2"></th><th>Patient 1</th><th>Patient 2</th></tr></thead><tbody><tr><td colspan="2">Gender</td><td>Male</td><td>Male</td></tr><tr><td colspan="2">Age</td><td>8 years</td><td>12 years</td></tr><tr><td colspan="4">Stature at birth</td></tr><tr><td></td><td>Weight (g)</td><td>2368</td><td>2470</td></tr><tr><td></td><td>OFC (cm)</td><td>29</td><td>33</td></tr><tr><td colspan="4">Stature at last examination</td></tr><tr><td></td><td>Height</td><td>[−4.0SD]</td><td>[−2.8SD]</td></tr><tr><td></td><td>Weight</td><td>[−2.3SD]</td><td>[−2.1SD]</td></tr><tr><td colspan="2">Early motor developmental delay</td><td>Mild</td><td>Moderate</td></tr><tr><td></td><td>Standing/walking</td><td>12 mo.</td><td>20 mo.</td></tr><tr><td colspan="2">Febrile seizures</td><td>+</td><td>+</td></tr><tr><td colspan="2">Intractable seizures</td><td>+</td><td>−</td></tr><tr><td colspan="2">Pyramidal sign</td><td>+</td><td>−</td></tr><tr><td colspan="2">Dysarthria</td><td>+</td><td>−</td></tr><tr><td colspan="2">Cerebellar signs</td><td>+</td><td>−</td></tr><tr><td colspan="2">Developmental deterioration</td><td>+</td><td>−</td></tr><tr><td colspan="2">Abnormal MRI findings</td><td>+</td><td>-</td></tr><tr><td colspan="2">Cognitive impairment</td><td>−</td><td>+</td></tr><tr><td colspan="2">Intellectual disability</td><td>−</td><td>+</td></tr><tr><td colspan="2">Severe autistic features</td><td>−</td><td>+</td></tr><tr><td colspan="4">Gene variants</td></tr><tr><td></td><td><italic>HSPD1</italic> p.Leu47Val</td><td>+</td><td>−</td></tr><tr><td></td><td><italic>HIP1</italic> p.Glu465Lys</td><td>−</td><td>+</td></tr><tr><td></td><td><italic>MECP2</italic> p.Arg167Trp</td><td>+</td><td>+</td></tr></tbody></table><table-wrap-foot><p><italic>OFC</italic> occipito-frontal circumference, <italic>SD</italic> standard deviation, <italic>mo</italic> months</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><title>Results of brain MRI and molecular investigations.</title><p>T1- (<bold>a</bold>) and T2-weighted axial images (<bold>b</bold>) of patient 1 examined at 4 years old. A –T2-high-signal is noted in the white matter, indicating hypomyelination. <bold>c</bold> Electropherograms of Sanger sequencing depicted in the family tree. Variants in <italic>HSPD1</italic> and <italic>HIP1</italic> are identified only in patient 1 and patient 2, respectively. Alternatively, the <italic>MECP2</italic> variant is identified in both patients as hemizygous and in their mother as heterozygous, indicating an X-linked recessive variant</p></caption><graphic id="d29e749" xlink:href="41439_2018_20_Fig1_HTML"></graphic></fig></p>
<p id="Par8">Protein secondary structures were predicted through web-based software provided by PRABI-Lyon-Gerland (The Institute of Biology and Chemistry of Proteins, Lyon, France; <ext-link ext-link-type="uri" xlink:href="https://prabi.ibcp.fr/htm/site/web/home">https://prabi.ibcp.fr/htm/site/web/home</ext-link>). A marked change was shown by <italic>HSPD1</italic> p.Leu47Val but not by <italic>HIP1</italic> p.Glu465Lys (Supplemental Figure <xref ref-type="media" rid="MOESM1">S2</xref>,<xref ref-type="media" rid="MOESM1">3</xref>).</p>
<p id="Par9">Patient 1 showed progressive paraplegia due to unknown leukodystrophy (Fig._<xref ref-type="fig" rid="Fig1">1a, b</xref>), and HLD4 was considered as a clinical diagnosis rather than SPG13. Although bi-allelic <italic>HSPD1</italic> involvement was expected<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, only a hemi-allelic involvement was confirmed. This may have reflected the existence of an unidentified variant in the non-coding region of <italic>HSPD1</italic>, because pathogenic CNVs were not observed. Another possible explanation is that HLD4 in this patient was caused by hemi-allelic involvement of <italic>HSPD1</italic>.</p>
<p id="Par10">An example of a gene related to both autosomal-recessive and dominant traits is the hepatic and glial cell adhesion molecule gene (<italic>HEPACAM</italic>)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Megalencephalic leukoencephalopathy with subcortical cysts 2A and B (MLC2A MIM#613925; MLC2B MIM#613926) is related to <italic>HEPACAM</italic> variants in recessive and dominant patterns, respectively. Although HLD4 and SPG13 are considered to be inherited through different modes, with autosomal-recessive and dominant traits, the main clinical features are commonly derived from pyramidal tract involvement owing to the dysfunction of myelin. Therefore, HLD4 and SPG13 may be involved in the same clinical spectrum, and the HLD4 in this patient may have been derived from hemi-allelic involvement in <italic>HSPD1</italic>, as in SPG13.</p>
<p id="Par11">Only four <italic>HSPD1</italic> variants, pVal98Ile<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, p.Gln461Glu<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, and p.Gly563Ala<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, have been reported as pathogenic variants for the autosomal dominant trait of SPG13, and only one homozygous variant, p.Asp29Gly, has been reported for the autosomal-recessive trait of HLD4<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, indicating that bi-allelic involvement is rare. In our in silico analysis of the novel variant of p.Leu47Val, a marked conformational change of HSPD1 protein was predicted. Thus, a dominant negative effect of p.Leu47Val was suspected, and it may have been responsible for the autosomal dominant trait of HLD4.</p>
<p id="Par12">In contrast to patient 1, patient 2 did not show any abnormal findings on brain MRI. This is reasonable because patient 2 did not have the <italic>HSPD1</italic> variant. Rather, he showed severe neuropsychiatric features, including ID, severe autistic features, and intractable epilepsy. WES identified a de novo <italic>HIP1</italic> (the huntingtin-interacting protein 1 gene) variant. <italic>HIP1</italic> is located on the neighboring region of the William syndrome critical region in 7q11.23, and atypically large deletions in 7q11.23 including <italic>HIP1</italic> have been identified in several patients<sup><xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR19">19</xref></sup>. Based on genotype-phenotype correlation studies for such cases, <italic>HIP1</italic> has been considered a candidate gene for neurological impairments. This is also supported by several functional studies<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. The de novo heterozygous <italic>HIP1</italic> variant identified in this study may suggest the previously considered hypothesis that <italic>HIP1</italic> is responsible for neurological impairments, although no marked protein conformational change was identified with a prediction tool.</p>
<p id="Par13">In the present sibling cases, a previously reported <italic>MECP2</italic> (the methyl CpG binding protein 2 gene) variant, p.Arg167Trp, was commonly observed as an X-linked recessive trait. This variant was previously identified in a three-generation family consisting of four individuals with non-specific X-linked ID<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Thus, p.Arg167Trp may have some clinical impact on the present sibling cases; however, patient 1 did not show developmental delay in the early stage. Thus, the severe neurological manifestations observed in patient 2 cannot be explained by the <italic>MECP2</italic> p.Arg167Trp variant.</p>
<p id="Par14">De novo variants are the major cause of neurodevelopmental disorders in childhood. In such cases, probands in their families are recognized as sporadic cases. Although de novo variants can be observed with an estimated background rate of 0.86 amino-acid-altering variants per newborn in controls<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, it would be rare for de novo variants to have a pathogenic impact on the proteins related to important functions. Thus, consecutive occurrence of de novo variants in the same family is an extremely rare phenomenon. Only a few cases of such consecutive occurrence of de novo variants have been reported<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Here, we observed different de novo variants in sibling cases with different phenotypic features.</p>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec3">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41439_2018_20_MOESM1_ESM.pdf"><caption><p>Supplemental Information</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Electronic supplementary material</title>
<p><bold>Supplementary information</bold> is available for this paper at 10.1038/s41439-018-0020-z.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This study was supported in part by grant from Japan Agency of Medical Research and Development, AMED (Practical Research Project for Rare/Intractable Diseases: 17ek0109270) and Grants-in Aid from the Research Committee of Development of Systems for the Diagnosis, Treatment, and Study of Inherited White Matter Disorders, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan.</p>
</ack>
<notes notes-type="data-availability">
<title>HGV database</title>
<p>The relevant data from this Data Report are hosted at the Human Genome Variation Database at: 10.6084/m9.figshare.hgv.2348; 10.6084/m9.figshare.hgv.2351; 10.6084/m9.figshare.hgv.2354</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar2">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Knaap</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Bugiani</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms</article-title>
<source/>Acta Neuropathol.
          <year>2017</year>
<volume>134</volume>
<fpage>351</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-017-1739-1</pub-id>
<pub-id pub-id-type="pmid">28638987</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Deon</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Hypomyelinating disorders: An MRI approach</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>87</volume>
<fpage>50</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.10.015</pub-id>
<pub-id pub-id-type="pmid">26477299</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charzewska</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hypomyelinating leukodystrophies—a molecular insight into the white matter pathology</article-title>
<source/>Clin. Genet.
          <year>2016</year>
<volume>90</volume>
<fpage>293</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12811</pub-id>
<pub-id pub-id-type="pmid">27234264</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashrafi</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Tavasoli</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Childhood leukodystrophies: a literature review of updates on new definitions, classification, diagnostic approach and management</article-title>
<source/>Brain. Dev.
          <year>2017</year>
<volume>39</volume>
<fpage>369</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2017.01.001</pub-id>
<pub-id pub-id-type="pmid">28117190</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ondo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A novel TUBB4A mutation G96R identified in a patient with hypomyelinating leukodystrophy onset beyond adolescence</article-title>
<source/>Hum. Genome Var.
          <year>2017</year>
<volume>4</volume>
<fpage>17035</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2017.35</pub-id>
<pub-id pub-id-type="pmid">28791129</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magen</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy</article-title>
<source/>Am. J. Hum. Genet.
          <year>2008</year>
<volume>83</volume>
<fpage>30</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2008.05.016</pub-id>
<pub-id pub-id-type="pmid">18571143</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60</article-title>
<source/>Am. J. Hum. Genet.
          <year>2002</year>
<volume>70</volume>
<fpage>1328</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.1086/339935</pub-id>
<pub-id pub-id-type="pmid">11898127</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pelizaeus-Merzbacher disease as a chromosomal disorder</article-title>
<source/>Congenit. Anom. (Kyoto).
          <year>2013</year>
<volume>53</volume>
<fpage>3</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/cga.12005</pub-id>
<pub-id pub-id-type="pmid">23480352</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biallelic mutations in nuclear pore complex subunit NUP107 cause early-childhood-onset steroid-resistant nephrotic syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2015</year>
<volume>97</volume>
<fpage>555</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.08.013</pub-id>
<pub-id pub-id-type="pmid">26411495</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higasa</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human genetic variation database, a reference database of genetic variations in the Japanese population</article-title>
<source/>J. Hum. Genet.
          <year>2016</year>
<volume>61</volume>
<fpage>547</fpage>
<pub-id pub-id-type="doi">10.1038/jhg.2016.12</pub-id>
<pub-id pub-id-type="pmid">26911352</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyatake</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an ‘exome-first’ approach</article-title>
<source/>J. Hum. Genet.
          <year>2015</year>
<volume>60</volume>
<fpage>175</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2014.124</pub-id>
<pub-id pub-id-type="pmid">25608832</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abecasis</surname>
<given-names>GR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrated map of genetic variation from 1,092 human genomes</article-title>
<source/>Nature
          <year>2012</year>
<volume>491</volume>
<fpage>56</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/nature11632</pub-id>
<pub-id pub-id-type="pmid">23128226</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi-Kabata</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing</article-title>
<source/>Hum. Genome Var.
          <year>2015</year>
<volume>2</volume>
<fpage>15050</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2015.50</pub-id>
<pub-id pub-id-type="pmid">27081555</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Hernandez</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism</article-title>
<source/>Am. J. Hum. Genet.
          <year>2011</year>
<volume>88</volume>
<fpage>422</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.009</pub-id>
<pub-id pub-id-type="pmid">21419380</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia</article-title>
<source/>J. Neurol.
          <year>2007</year>
<volume>254</volume>
<fpage>897</fpage>
<lpage>900</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-006-0470-y</pub-id>
<pub-id pub-id-type="pmid">17420924</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hewamadduma</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HSP60 is a rare cause of hereditary spastic paraparesis, but may act as a genetic modifier</article-title>
<source/>Neurology
          <year>2008</year>
<volume>70</volume>
<fpage>1717</fpage>
<lpage>1718</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000311395.31081.70</pub-id>
<pub-id pub-id-type="pmid">18458233</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fusco</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2014</year>
<volume>22</volume>
<fpage>64</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2013.101</pub-id>
<pub-id pub-id-type="pmid">23756441</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komoike</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly</article-title>
<source/>Genesis
          <year>2010</year>
<volume>48</volume>
<fpage>233</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">20146355</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent distal 7q11.23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems</article-title>
<source/>Am. J. Hum. Genet.
          <year>2010</year>
<volume>87</volume>
<fpage>857</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.10.019</pub-id>
<pub-id pub-id-type="pmid">21109226</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Huntingtin-interacting protein 1-related protein plays a critical role in dendritic development and excitatory synapse formation in hippocampal neurons</article-title>
<source/>Front. Mol. Neurosci.
          <year>2017</year>
<volume>10</volume>
<fpage>186</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00186</pub-id>
<pub-id pub-id-type="pmid">28663723</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metzler</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking</article-title>
<source/>EMBO J.
          <year>2003</year>
<volume>22</volume>
<fpage>3254</fpage>
<lpage>3266</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdg334</pub-id>
<pub-id pub-id-type="pmid">12839988</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Couvert</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 is highly mutated in X-linked mental retardation</article-title>
<source/>Hum. Mol. Genet.
          <year>2001</year>
<volume>10</volume>
<fpage>941</fpage>
<lpage>946</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.9.941</pub-id>
<pub-id pub-id-type="pmid">11309367</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A de novo paradigm for mental retardation</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>1109</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1038/ng.712</pub-id>
<pub-id pub-id-type="pmid">21076407</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasmant</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family</article-title>
<source/>Am. J. Med. Genet. A.
          <year>2012</year>
<volume>158A</volume>
<fpage>2290</fpage>
<lpage>2291</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35496</pub-id>
<pub-id pub-id-type="pmid">22847776</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>